Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Alx Oncology Holdings (ALXO) Revenue (2019 - 2020)

Alx Oncology Holdings' Revenue history spans 2 years, with the latest figure at $527000.0 for Q2 2020.

  • On a quarterly basis, Revenue fell 59.31% to $527000.0 in Q2 2020 year-over-year; TTM through Mar 2021 was $527000.0, a 88.07% decrease, with the full-year FY2020 number at $1.2 million, down 75.35% from a year prior.
  • Revenue hit $527000.0 in Q2 2020 for Alx Oncology Holdings, down from $655000.0 in the prior quarter.
  • Over the last five years, Revenue for ALXO hit a ceiling of $1.3 million in Q2 2019 and a floor of $527000.0 in Q2 2020.